As of 2025-07-01, the Relative Valuation of Syndax Pharmaceuticals Inc (SNDX) is (78.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.37 USD, the upside of Syndax Pharmaceuticals Inc based on Relative Valuation is -938.4%.
The range of the Relative Valuation is (63.89) - (87.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 22.8x | 19.0x |
| Forward P/E multiples | 16.6x - 27.1x | 21.8x |
| Fair Price | (63.89) - (87.60) | (78.52) |
| Upside | -782.3% - -1035.4% | -938.4% |
| Date | P/E |
| 2025-06-26 | -2.42 |
| 2025-06-25 | -2.31 |
| 2025-06-24 | -2.40 |
| 2025-06-23 | -2.39 |
| 2025-06-20 | -2.46 |
| 2025-06-18 | -2.52 |
| 2025-06-17 | -2.50 |
| 2025-06-16 | -2.60 |
| 2025-06-13 | -2.66 |
| 2025-06-12 | -2.77 |
| 2025-06-11 | -2.83 |
| 2025-06-10 | -2.92 |
| 2025-06-09 | -2.88 |
| 2025-06-06 | -2.97 |
| 2025-06-05 | -2.90 |
| 2025-06-04 | -2.85 |
| 2025-06-03 | -2.91 |
| 2025-06-02 | -2.85 |
| 2025-05-30 | -2.74 |
| 2025-05-29 | -2.76 |
| 2025-05-28 | -2.63 |
| 2025-05-27 | -2.58 |
| 2025-05-23 | -2.56 |
| 2025-05-22 | -2.81 |
| 2025-05-21 | -2.77 |
| 2025-05-20 | -2.75 |
| 2025-05-19 | -2.42 |
| 2025-05-16 | -2.35 |
| 2025-05-15 | -2.33 |
| 2025-05-14 | -2.41 |
| 2025-05-13 | -2.65 |
| 2025-05-12 | -2.86 |
| 2025-05-09 | -2.78 |
| 2025-05-08 | -2.86 |
| 2025-05-07 | -2.60 |
| 2025-05-06 | -2.76 |
| 2025-05-05 | -3.53 |
| 2025-05-02 | -3.57 |
| 2025-05-01 | -3.59 |
| 2025-04-30 | -3.68 |
| 2025-04-29 | -3.56 |
| 2025-04-28 | -3.49 |
| 2025-04-25 | -3.46 |
| 2025-04-24 | -3.46 |
| 2025-04-23 | -3.38 |
| 2025-04-22 | -3.36 |
| 2025-04-21 | -3.10 |
| 2025-04-17 | -3.00 |
| 2025-04-16 | -2.87 |
| 2025-04-15 | -2.94 |